Skip to main content

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.

Clinical Trials

BRCC Research Institute 2026

< All Clinical Trials

A double blind trial of PF-08634404 + Chemo vs. Bevacizumab + Chemo in untreated colon cancer

Disease Type: Colon

An Interventional, Phase 3, Double-blind, Randomized Study To Evaluate The Efficacy And Safety Of Pf-08634404 In Combination With Chemotherapy Versus Bevacizumab In Combination With Chemotherapy In Treatment-naïve Participants With Metastatic Colorectal Cancer

Locations

Alleghany , Blacksburg , Roanoke , Salem , Wytheville

View on ClinicalTrials.gov